
============================================================
                   AKTIENANALYSE: BAYN.DE                   
============================================================
Firmendaten werden abgerufen...
+-------------+------------------------------+------------------------------+
| Kategorie   | Details                      | ErlÃ¤uterung                  |
+=============+==============================+==============================+
| Unternehmen | Bayer Aktiengesellschaft     | Name des Unternehmens        |
+-------------+------------------------------+------------------------------+
| Sektor      | Healthcare                   | Wirtschaftssektor            |
+-------------+------------------------------+------------------------------+
| Branche     | Drug Manufacturers - General | Industrie oder GeschÃ¤ftsfeld |
+-------------+------------------------------+------------------------------+
| Land        | Germany                      | Herkunftsland                |
+-------------+------------------------------+------------------------------+

Kurzbeschreibung: Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides pr...

Historische Daten werden abgerufen...

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
            DCF SCHÃ„TZUNG & SZENARIEN             
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
DCF SchÃ¤tzung nicht mÃ¶glich (unzureichende Daten oder FCF ist 0).

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
               SENSITIVITÃ„TSANALYSE               
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-----------------+----------------------+------------+
| Wachstumsrate   | Diskontierungsrate   | DCF Wert   |
+=================+======================+============+
| Wachstum 0.0%   | Diskontierung 0.1%   | N/A        |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | N/A        |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | N/A        |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | N/A        |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | N/A        |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | N/A        |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | N/A        |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | N/A        |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | N/A        |
+-----------------+----------------------+------------+

==============================
Gesamtbewertung abgeschlossen 
==============================

+-------------+-------------------------+------------------------------+
| Kategorie   | Details                 | ErlÃ¤uterung                  |
+=============+=========================+==============================+
| Unternehmen | Rivian Automotive, Inc. | Name des Unternehmens        |
+-------------+-------------------------+------------------------------+
| Sektor      | Consumer Cyclical       | Wirtschaftssektor            |
+-------------+-------------------------+------------------------------+
| Branche     | Auto Manufacturers      | Industrie oder GeschÃ¤ftsfeld |
+-------------+-------------------------+------------------------------+
| Land        | United States           | Herkunftsland                |
+-------------+-------------------------+------------------------------+
+----------------+--------+---------------------------------+
| Kategorie      | Wert   | ErlÃ¤uterung                     |
+================+========+=================================+
| Aktueller Kurs | $13.57 | Letzter Schlusskurs             |
+----------------+--------+---------------------------------+
| TagesÃ¤nderung  | -1.5%  | Prozentuale Ã„nderung zum Vortag |
+----------------+--------+---------------------------------+
| Volumen        | N/A    | Gehandeltes Volumen             |
+----------------+--------+---------------------------------+
| MA(20)         | $14.35 | 20-Tage-Durchschnitt            |
+----------------+--------+---------------------------------+
| MA(50)         | $13.76 | 50-Tage-Durchschnitt            |
+----------------+--------+---------------------------------+
| MA(200)        | $12.52 | 200-Tage-Durchschnitt           |
+----------------+--------+---------------------------------+
| RSI(14)        | 38.5   | Relative Strength Index         |
+----------------+--------+---------------------------------+
| 52W Hoch       | $28.06 | 52-Wochen-HÃ¶chstkurs            |
+----------------+--------+---------------------------------+
| 52W Tief       | $8.26  | 52-Wochen-Tiefstkurs            |
+----------------+--------+---------------------------------+
| VolatilitÃ¤t    | 73.6%  | JÃ¤hrliche VolatilitÃ¤t           |
+----------------+--------+---------------------------------+
+----------------------+--------------------+-----------------------------------------+
| Kategorie            | Wert               | ErlÃ¤uterung                             |
+======================+====================+=========================================+
| Marktkapitalisierung | $15,556,918,272.00 | Gesamtwert der Aktien                   |
+----------------------+--------------------+-----------------------------------------+
| KGV (P/E)            | N/A                | Kurs-Gewinn-VerhÃ¤ltnis                  |
+----------------------+--------------------+-----------------------------------------+
| Forward P/E          | -4.95              | Erwartetes KGV                          |
+----------------------+--------------------+-----------------------------------------+
| Dividendenrendite    | N/A                | Dividende im VerhÃ¤ltnis zum Kurs        |
+----------------------+--------------------+-----------------------------------------+
| Verschuldungsgrad    | 78.15              | VerhÃ¤ltnis von Schulden zu Eigenkapital |
+----------------------+--------------------+-----------------------------------------+
+--------------------+--------+------------------------------+
| Kategorie          | Wert   | ErlÃ¤uterung                  |
+====================+========+==============================+
| Analysten-Kursziel | $14.87 | Durchschnittliches Kursziel  |
+--------------------+--------+------------------------------+
| Upside-Potenzial   | 9.6%   | Potenzial fÃ¼r Kurssteigerung |
+--------------------+--------+------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
           AKTIENSTRATEGIE & EMPFEHLUNG           
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-------------------+----------------------------------------------------+--------------------------------------------+
| Kategorie         | Wert                                               | ErlÃ¤uterung                                |
+===================+====================================================+============================================+
| Kategorie         | Wert                                               | ErlÃ¤uterung                                |
+-------------------+----------------------------------------------------+--------------------------------------------+
| Gesamtempfehlung  | ðŸŸ¡ Halten                                           | Zusammenfassende Bewertung der Aktie.      |
+-------------------+----------------------------------------------------+--------------------------------------------+
| StÃ¤rken           | Keine besonderen StÃ¤rken                           | Positive Aspekte der Analyse.              |
+-------------------+----------------------------------------------------+--------------------------------------------+
| SchwÃ¤chen/Risiken | Hoher Verschuldungsgrad                            | Negative Aspekte oder potenzielle Risiken. |
+-------------------+----------------------------------------------------+--------------------------------------------+
| BegrÃ¼ndung        | Forward P/E: -4.95, Dividende: N/A, DCF: N/A (EUR) | GrÃ¼nde fÃ¼r die Bewertung.                  |
+-------------------+----------------------------------------------------+--------------------------------------------+
| Kaufzone          | N/A (EUR)                                          | Preisbereich fÃ¼r den Einstieg.             |
+-------------------+----------------------------------------------------+--------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                DIVIDENDENWACHSTUM                
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
            DCF SCHÃ„TZUNG & SZENARIEN             
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+--------------------------+------------+----------+---------------------------------------------+
| Szenario                 | DCF Wert   | Upside   | Annahmen                                    |
+==========================+============+==========+=============================================+
| Basis-Szenario           | $59.16     | -31.5%   | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Optimistisches Szenario  | $75.26     | -12.8%   | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Pessimistisches Szenario | $42.27     | -51.0%   | Annahmen: Wachstum 0.0%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
               SENSITIVITÃ„TSANALYSE               
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-----------------+----------------------+------------+
| Wachstumsrate   | Diskontierungsrate   | DCF Wert   |
+=================+======================+============+
| Wachstum 0.0%   | Diskontierung 0.1%   | $42.27     |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $54.34     |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $63.40     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $45.89     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $59.16     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $69.12     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $49.77     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $64.33     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $75.26     |
+-----------------+----------------------+------------+

==============================
Gesamtbewertung abgeschlossen 
==============================

+-------------+-----------------+------------------------------+
| Kategorie   | Details         | ErlÃ¤uterung                  |
+=============+=================+==============================+
| Unternehmen | Medtronic plc   | Name des Unternehmens        |
+-------------+-----------------+------------------------------+
| Sektor      | Healthcare      | Wirtschaftssektor            |
+-------------+-----------------+------------------------------+
| Branche     | Medical Devices | Industrie oder GeschÃ¤ftsfeld |
+-------------+-----------------+------------------------------+
| Land        | Ireland         | Herkunftsland                |
+-------------+-----------------+------------------------------+
+----------------+--------+---------------------------------+
| Kategorie      | Wert   | ErlÃ¤uterung                     |
+================+========+=================================+
| Aktueller Kurs | $86.34 | Letzter Schlusskurs             |
+----------------+--------+---------------------------------+
| TagesÃ¤nderung  | 0.7%   | Prozentuale Ã„nderung zum Vortag |
+----------------+--------+---------------------------------+
| Volumen        | N/A    | Gehandeltes Volumen             |
+----------------+--------+---------------------------------+
| MA(20)         | $85.21 | 20-Tage-Durchschnitt            |
+----------------+--------+---------------------------------+
| MA(50)         | $84.55 | 50-Tage-Durchschnitt            |
+----------------+--------+---------------------------------+
| MA(200)        | $86.37 | 200-Tage-Durchschnitt           |
+----------------+--------+---------------------------------+
| RSI(14)        | 66.5   | Relative Strength Index         |
+----------------+--------+---------------------------------+
| 52W Hoch       | $95.49 | 52-Wochen-HÃ¶chstkurs            |
+----------------+--------+---------------------------------+
| 52W Tief       | $65.49 | 52-Wochen-Tiefstkurs            |
+----------------+--------+---------------------------------+
| VolatilitÃ¤t    | 20.2%  | JÃ¤hrliche VolatilitÃ¤t           |
+----------------+--------+---------------------------------+
+----------------------+---------------------+-----------------------------------------+
| Kategorie            | Wert                | ErlÃ¤uterung                             |
+======================+=====================+=========================================+
| Marktkapitalisierung | $110,681,833,472.00 | Gesamtwert der Aktien                   |
+----------------------+---------------------+-----------------------------------------+
| KGV (P/E)            | 23.92               | Kurs-Gewinn-VerhÃ¤ltnis                  |
+----------------------+---------------------+-----------------------------------------+
| Forward P/E          | 14.76               | Erwartetes KGV                          |
+----------------------+---------------------+-----------------------------------------+
| Dividendenrendite    | 3.29%               | Dividende im VerhÃ¤ltnis zum Kurs        |
+----------------------+---------------------+-----------------------------------------+
| Verschuldungsgrad    | 59.09               | VerhÃ¤ltnis von Schulden zu Eigenkapital |
+----------------------+---------------------+-----------------------------------------+
+--------------------+--------+------------------------------+
| Kategorie          | Wert   | ErlÃ¤uterung                  |
+====================+========+==============================+
| Analysten-Kursziel | $96.09 | Durchschnittliches Kursziel  |
+--------------------+--------+------------------------------+
| Upside-Potenzial   | 11.3%  | Potenzial fÃ¼r Kurssteigerung |
+--------------------+--------+------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
           AKTIENSTRATEGIE & EMPFEHLUNG           
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-------------------+----------------------------------------------------------------------+--------------------------------------------+
| Kategorie         | Wert                                                                 | ErlÃ¤uterung                                |
+===================+======================================================================+============================================+
| Kategorie         | Wert                                                                 | ErlÃ¤uterung                                |
+-------------------+----------------------------------------------------------------------+--------------------------------------------+
| Gesamtempfehlung  | ðŸŸ¢ Kaufen                                                             | Zusammenfassende Bewertung der Aktie.      |
+-------------------+----------------------------------------------------------------------+--------------------------------------------+
| StÃ¤rken           | Hohe Dividendenrendite                                               | Positive Aspekte der Analyse.              |
+-------------------+----------------------------------------------------------------------+--------------------------------------------+
| SchwÃ¤chen/Risiken | Hoher Verschuldungsgrad                                              | Negative Aspekte oder potenzielle Risiken. |
+-------------------+----------------------------------------------------------------------+--------------------------------------------+
| BegrÃ¼ndung        | Forward P/E: 14.76, Dividende: 329.00%, DCF: 59.15830211811096 (EUR) | GrÃ¼nde fÃ¼r die Bewertung.                  |
+-------------------+----------------------------------------------------------------------+--------------------------------------------+
| Kaufzone          | 59.15830211811096 (EUR)                                              | Preisbereich fÃ¼r den Einstieg.             |
+-------------------+----------------------------------------------------------------------+--------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                DIVIDENDENWACHSTUM                
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
            DCF SCHÃ„TZUNG & SZENARIEN             
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+--------------------------+------------+----------+---------------------------------------------+
| Szenario                 | DCF Wert   | Upside   | Annahmen                                    |
+==========================+============+==========+=============================================+
| Basis-Szenario           | $112.66    | 18.7%    | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Optimistisches Szenario  | $143.33    | 51.0%    | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Pessimistisches Szenario | $80.49     | -15.2%   | Annahmen: Wachstum 0.0%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
               SENSITIVITÃ„TSANALYSE               
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-----------------+----------------------+------------+
| Wachstumsrate   | Diskontierungsrate   | DCF Wert   |
+=================+======================+============+
| Wachstum 0.0%   | Diskontierung 0.1%   | $80.49     |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $103.48    |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $120.73    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $87.38     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $112.66    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $131.62    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $94.78     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $122.51    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $143.33    |
+-----------------+----------------------+------------+

==============================
Gesamtbewertung abgeschlossen 
==============================

+-------------+------------------------------+------------------------------+
| Kategorie   | Details                      | ErlÃ¤uterung                  |
+=============+==============================+==============================+
| Unternehmen | Novartis AG                  | Name des Unternehmens        |
+-------------+------------------------------+------------------------------+
| Sektor      | Healthcare                   | Wirtschaftssektor            |
+-------------+------------------------------+------------------------------+
| Branche     | Drug Manufacturers - General | Industrie oder GeschÃ¤ftsfeld |
+-------------+------------------------------+------------------------------+
| Land        | Switzerland                  | Herkunftsland                |
+-------------+------------------------------+------------------------------+
+----------------+---------+---------------------------------+
| Kategorie      | Wert    | ErlÃ¤uterung                     |
+================+=========+=================================+
| Aktueller Kurs | $94.89  | Letzter Schlusskurs             |
+----------------+---------+---------------------------------+
| TagesÃ¤nderung  | -0.3%   | Prozentuale Ã„nderung zum Vortag |
+----------------+---------+---------------------------------+
| Volumen        | N/A     | Gehandeltes Volumen             |
+----------------+---------+---------------------------------+
| MA(20)         | $95.35  | 20-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(50)         | $92.59  | 50-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(200)        | $92.51  | 200-Tage-Durchschnitt           |
+----------------+---------+---------------------------------+
| RSI(14)        | 54.9    | Relative Strength Index         |
+----------------+---------+---------------------------------+
| 52W Hoch       | $100.44 | 52-Wochen-HÃ¶chstkurs            |
+----------------+---------+---------------------------------+
| 52W Tief       | $73.70  | 52-Wochen-Tiefstkurs            |
+----------------+---------+---------------------------------+
| VolatilitÃ¤t    | 18.1%   | JÃ¤hrliche VolatilitÃ¤t           |
+----------------+---------+---------------------------------+
+----------------------+---------------------+-----------------------------------------+
| Kategorie            | Wert                | ErlÃ¤uterung                             |
+======================+=====================+=========================================+
| Marktkapitalisierung | $187,416,297,472.00 | Gesamtwert der Aktien                   |
+----------------------+---------------------+-----------------------------------------+
| KGV (P/E)            | 18.14               | Kurs-Gewinn-VerhÃ¤ltnis                  |
+----------------------+---------------------+-----------------------------------------+
| Forward P/E          | 15.35               | Erwartetes KGV                          |
+----------------------+---------------------+-----------------------------------------+
| Dividendenrendite    | 3.69%               | Dividende im VerhÃ¤ltnis zum Kurs        |
+----------------------+---------------------+-----------------------------------------+
| Verschuldungsgrad    | 81.32               | VerhÃ¤ltnis von Schulden zu Eigenkapital |
+----------------------+---------------------+-----------------------------------------+
+--------------------+--------+------------------------------+
| Kategorie          | Wert   | ErlÃ¤uterung                  |
+====================+========+==============================+
| Analysten-Kursziel | $97.08 | Durchschnittliches Kursziel  |
+--------------------+--------+------------------------------+
| Upside-Potenzial   | 2.3%   | Potenzial fÃ¼r Kurssteigerung |
+--------------------+--------+------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
           AKTIENSTRATEGIE & EMPFEHLUNG           
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| Kategorie         | Wert                                                                  | ErlÃ¤uterung                                |
+===================+=======================================================================+============================================+
| Kategorie         | Wert                                                                  | ErlÃ¤uterung                                |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| Gesamtempfehlung  | ðŸŸ¡ Halten                                                              | Zusammenfassende Bewertung der Aktie.      |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| StÃ¤rken           | Hohe Dividendenrendite,                                               | Positive Aspekte der Analyse.              |
|                   | Geringe VolatilitÃ¤t                                                   |                                            |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| SchwÃ¤chen/Risiken | Hoher Verschuldungsgrad                                               | Negative Aspekte oder potenzielle Risiken. |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| BegrÃ¼ndung        | Forward P/E: 15.35, Dividende: 369.00%, DCF: 112.65842913411893 (EUR) | GrÃ¼nde fÃ¼r die Bewertung.                  |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| Kaufzone          | 112.65842913411893 (EUR)                                              | Preisbereich fÃ¼r den Einstieg.             |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                DIVIDENDENWACHSTUM                
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Keine ausreichenden Daten fÃ¼r Dividendenwachstum verfÃ¼gbar.
